I'm using postgresql in a program that uses ':' to denote parameters to replace. IE if I have a parameter called 'parameter_id', in the query I would put :parameter_id which would be replaced by the ...
State Key Laboratory of Precision and Intelligent Chemistry, University of Science and Technology of China, Hefei 230026, China ...
Abstract: Under the flux-weakening (FW) operation, the sensorless control of a five-phase flux-intensifying permanent magnet (FP-FIPM) motor faces the dilemma of reduced torque output and poor ...
Forward-looking: Forget about putting data centers underwater; the next step could be placing them in outer space. A US startup aims to prove this is possible by launching a satellite carrying H100 ...
"In 10 years, nearly all new data centers will be being built in outer space." An NVIDIA GPU is heading toward its record-setting orbital debut, a trip that will test how data centers could work in ...
WASHINGTON — Apex, a Los Angeles-based satellite manufacturing startup, is investing its own capital to demonstrate it can build and deploy interceptors in space for Golden Dome, a planned missile ...
Apex has announced its forthcoming Project Shadow mission, to demonstrate space-based interceptor technology within the next year. Credit: Apex Satellite bus manufacturer Apex is funding and ...
Satellite bus designer and manufacturer Apex next summer plans to demonstrate commercially-developed space-based interceptor (SBI) technology to reduce risk for a key component of the Trump ...
The $2.8 million UG3 grant will fund the study, “Exploiting accelerated aging associated with Low Earth Orbit (LEO) environment to gain insights into pathogenesis and treatment of progressive ...
Oman’s dream for a spaceport sits in a swath of desert overlooking the Arabian Sea. If all goes according to plan, three separate complexes here will launch everything from small suborbital rockets ...
WILMINGTON, Del.--(BUSINESS WIRE)--Positive results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI ® (durvalumab) in combination with standard-of-care ...
At five years, KEYTRUDA plus LENVIMA showed a 16.7% overall survival (OS) rate for these patients with mismatch repair proficient (pMMR) advanced endometrial carcinoma versus 7.3% for chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback